Annals of Emergency Medicine
Volume 39, Issue 3 , Pages 215-222 , March 2002

Treatment patterns of isolated benign headache in US emergency departments

  • David R. Vinson, MD
    • ,
  • Author contribution is provided at the end of this article. Author contribution: DRV is the sole author and takes responsibility for the paper as a whole.

Received 9 August 2001 ,Revised 23 October 2001 ,Accepted 30 October 2001.

References 

  1. Linet MS, Stewart WF, Celentano DD, et al.  An epidemiologic study of headache among adolescents and young adults. JAMA. 1989;261:2211–2216
  2. Field AG, Wang E. Evaluation of the patient with nontraumatic headache: an evidence based approach. Emerg Med Clin North Am. 1999;17:127–152
  3. Bartleson JD. Treatment of migraine headaches. Mayo Clin Proc. 1999;74:702–708
  4. Gray RN, McCrory DC, Eberlein K, et al.  Parenteral drug treatments for acute migraine headache. Technical review, 2.5. February 1999 (prepared for the Agency for Health Care Policy and Research under Contract No. 290-94-2025) NTIS Accession No. 127862. May be ordered online Springfield, VA: National Technical Information Service; 1999; http://www.ntis.gov
  5. Ferrari MD. Migraine. Lancet. 1998;351:1043–1051
  6. Capobianco DJ, Cheshire WP, Campbell JK. An overview of the diagnosis and pharmacologic treatment of migraine. Mayo Clin Proc. 1996;71:1055–1066
  7. Pryse-Phillips WE, Dodick DW, Edmeads JG, et al.  Guidelines for the diagnosis and management of migraine in clinical practice. Canadian Headache Society. Can Med Assoc J. 1997;156:1273–1287
  8. Matchar DB, Young WB, Rosenberg JH, et al.  Evidence-based guidelines for migraine headaches in the primary care setting: pharmacological management of acute attacks. Neurology. 2000; American Academy of Neurology US Headache Consortium Available at http://www.aan.com/public/practiceguidelines Accessed December 23, 2001
  9. Centers for Disease Control and Prevention . National Center for Health Statistics, Ambulatory Health Care Data, National Hospital Ambulatory Medical Care Survey, Public-use Data Files. 1998; Available at http://www.cdc.gov/nchs/about/major/ahcd/ahcd1.htm Accessed December 23, 2001
  10. Coppola M, Yealy DM, Leibold RA. Randomized, placebo-controlled evaluation of prochlorperazine versus metoclopramide for emergency department treatment of migraine headache. Ann Emerg Med. 1995;26:541–546
  11. Jones J, Pack S, Chun E. Intramuscular prochlorperazine versus metoclopramide as single-agent therapy for the treatment of acute migraine headache. Am J Emerg Med. 1996;14:262–264
  12. Cameron JD, Lane PL, Speechley M. Intravenous chlorpromazine vs intravenous metoclopramide in acute migraine headache. Acad Emerg Med. 1995;2:597–602
  13. Bell R, Montoya D, Shuaib A, et al.  A comparative trial of three agents in the treatment of acute migraine headache. Ann Emerg Med. 1990;19:1079–1082
  14. Shrestha M, Singh R, Moreden J, et al.  Ketorolac vs chlorpromazine in the treatment of acute migraine without aura. A prospective, randomized, double-blind trial. Arch Intern Med. 1996;156:1725–1728
  15. Winner P, Ricalde O, Le Force B, et al.  A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine. Arch Neurol. 1996;53:180–184
  16. Lane PL, McLellan BA, Baggoley CJ. Comparative efficacy of chlorpromazine and meperidine with dimenhydrinate in migraine headache. Ann Emerg Med. 1989;18:360–365
  17. Larkin GL, Prescott JE. A randomized, double-blind, comparative study of the efficacy of ketorolac tromethamine versus meperidine in the treatment of severe migraine. Ann Emerg Med. 1992;21:919–924
  18. Belgrade MJ, Ling LJ, Schleevogt MB, et al.  Comparison of single-dose meperidine, butorphanol, and dihydroergotamine in the treatment of vascular headache. Neurology. 1989;39:590–592
  19. Scherl ER, Wilson JF. Comparison of dihydroergotamine with metoclopramide versus meperidine with promethazine in the treatment of acute migraine. Headache. 1995;35:256–259
  20. Clark RF, Wei EM, Anderson PO. Meperidine: therapeutic use and toxicity. J Emerg Med. 1995;13:797–802
  21. Silverman ME, Shih RD. Morphine causes less nausea than meperidine when used as an analgesic in the ED [abstract]. Acad Emerg Med. 2001;8:430–431
  22. Talbot-Stern J, Paoloni R. Prophylactic metoclopramide is unnecessary with intravenous analgesia in the ED. Am J Emerg Med. 2000;18:653–657
  23. Ernst AA, Weiss SJ, Park S, et al.  Prochlorperazine versus promethazine for uncomplicated nausea and vomiting in the emergency department: a randomized, double-blind clinical trial. Ann Emerg Med. 2000;36:89–94
  24. Miner JR, Fish SJ, Smith SW, et al.  Droperidol vs. prochlorperazine for benign headaches in the emergency department. Acad Emerg Med. 2001;8:873–879
  25. Kelly AM. Migraine: pharmacotherapy in the emergency department. J Accid Emerg Med. 2000;17:241–245
  26. Thomas SH, Stone CK. Emergency department treatment of migraine, tension, and mixed-type headache. J Emerg Med. 1994;12:657–664
  27. Vinson DR, Drotts DL. Diphenhydramine for the prevention of akathisia induced by prochlorperazine: a randomized, controlled trial. Ann Emerg Med. 2001;37:125–131
  28. Maizels M. Headache evaluation and treatment by primary care physicians in an emergency department in the era of triptans. Arch Intern Med. 2001;161:1969–1973
  29. Ward TN, Levin M, Phillips JM. Evaluation and management of headache in the emergency department. Med Clin North Am. 2001;85:971–985
  30. Cabana MD, Rand CS, Powe NR, et al.  Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999;282:1458–1465
  31. Wyszewianski L, Green LA. Strategies for changing clinicians' practice patterns. A new perspective. J Fam Pract. 2000;49:461–464
  32. Salomone JA, Thomas RW, Althoff JR, et al.  An evaluation of the role of the ED in the management of migraine headaches. Am J Emerg Med. 1994;12:134–137
  33. Klapper JA, Stanton J. Current emergency treatment of severe migraine headaches. Headache. 1993;33:560–562
  34. The Headache Classification Committee of the International Headache Society . Classification and diagnostic criteria for headache disorders, cranial neuralgias, and facial pain. Cephalalgia. 1988;8(Suppl 7):1–96
  35. Solomon S. Diagnosis of primary headache disorders. Validity of the International Headache Society criteria in clinical practice. Neurol Clin. 1997;15:15–26
  36. Fiesseler FW, Richman PB, Mandell M, et al.  The International Headache Society definition of acute migraine headache: do emergency department patients with headaches meet these criteria [abstract]?. Acad Emerg Med. 2001;8:508–509
  37. Rains J, Penzien D, Lipchik G, et al.  Diagnosis of migraine: empirical analysis of a large clinical sample of atypical migraine (IHS 1.7) patients and proposed revision of the IHS criteria. Cephalalgia. 2001;21:584–595
  38. Lipton RB, Stewart WF, Cady R, et al.  Sumatriptan for the range of headaches in migraine sufferers: results of the Spectrum Study. Headache. 2000;40:783–791

☆ Address for reprints: David R. Vinson, MD, Department of Emergency Medicine, Kaiser Permanente Medical Center, 1600 Eureka Road, Roseville, CA 95661-3027.

PII: S0196-0644(02)95261-3

doi: 10.1067/mem.2002.121400

Annals of Emergency Medicine
Volume 39, Issue 3 , Pages 215-222 , March 2002

Article Tools

* Image Usage & Resolution